Point72 Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.04M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $15.1M | Sell |
|
|||||
|
2024
Q2 | $18.8M | Buy |
|
|||||
|
2024
Q1 | $11.9M | Sell |
|
|||||
|
2023
Q4 | $40.3M | Sell |
|
|||||
|
2023
Q3 | $38.5M | Buy |
|
|||||
|
2023
Q2 | $5.71M | Sell |
|
|||||
|
2023
Q1 | $18.1M | Sell |
|
|||||
|
2022
Q4 | $46.5M | Sell |
|
|||||
|
2022
Q3 | $59.2M | Buy |
|
|||||
|
2022
Q2 | $27.4M | Sell |
|
|||||
|
2022
Q1 | $65.6M | Sell |
|
|||||
|
2021
Q4 | $93.5M | Buy |
|
|||||
|
2021
Q3 | $16.5M | Buy |
|
|||||
|
2021
Q2 | $16.8M | Buy |
|
|||||
|
2021
Q1 | $13.6M | Buy |
|
|||||
|
2020
Q4 | $7.27M | Buy |
|
|||||
|
2020
Q3 | $4.95M | Sell |
|
|||||
|
2020
Q2 | $8.27M | Buy |
|
|||||
|
2020
Q1 | $6.63M | Sell |
|
|||||
|
2019
Q4 | $11.2M | Sell |
|
|||||
|
2019
Q3 | $8.33M | Hold |
|
|||||
|
2019
Q2 | $9.12M | Buy |
|
|||||
|
2019
Q1 | $8.64M | Buy |
|
|||||
|
2018
Q4 | $4.58M | Buy |
|
|||||
|
2018
Q3 | $5.28M | Buy |
|
|||||
|
2018
Q2 | $719K | Sell |
|
|||||
|
2018
Q1 | $1.5M | Sell |
|
|||||
|
2017
Q4 | $876K | Hold |
|
|||||
|
2017
Q3 | $915K | Hold |
|
|||||
|
2017
Q2 | $977K | Hold |
|
|||||
|
2017
Q1 | $1.24M | Hold |
|
|||||
|
2016
Q4 | $2.39M | Sell |
|
|||||
|
2016
Q3 | $2.9M | Hold |
|
|||||
|
2016
Q2 | $2.12M | Hold |
|
|||||
|
2016
Q1 | $2.51M | Buy |
|
|||||
|
2015
Q4 | $2.55M | Hold |
|
|||||
|
2015
Q3 | $2.62M | Buy |
|
|||||
|
2015
Q2 | $3.08M | Buy |
|
|||||
|
2015
Q1 | $1.85M | Buy |
|